POMC and Hyperlordosis: Lordosis can be inhibited or facilitated by alpha-MSH, an MC3/4R agonist; alpha-MSH receives signaling from estradiol to activate the neural pathways required for lordosis (Pfaus et al., 2004; Tsukahara et al., 2014).